$1.47
5.00% today
Nasdaq, Oct 31, 09:00 pm CET
ISIN
US1570851014
Symbol
CERS

Cerus Corporation Stock price

$1.47
-0.12 7.55% 1M
+0.15 11.36% 6M
-0.07 4.55% YTD
-0.10 6.37% 1Y
-2.19 59.84% 3Y
-3.88 72.52% 5Y
-3.60 71.01% 10Y
-5.16 77.83% 20Y
Nasdaq, Closing price Fri, Oct 31 2025
+0.07 5.00%

Key metrics

Basic
Market capitalization
$268.4m
Enterprise Value
$275.3m
Net debt
$6.9m
Cash
$78.0m
Shares outstanding
191.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.2 | 1.3
EV/Sales
1.3 | 1.3
EV/FCF
80.5
P/B
4.8
Financial Health
Equity Ratio
27.9%
Return on Equity
-37.3%
ROCE
-9.1%
ROIC
-11.6%
Debt/Equity
1.5
Financials (TTM | estimate)
Revenue
$216.4m | $214.6m
EBITDA
$-10.3m | $8.0m
EBIT
$-11.7m | $-14.4m
Net Income
$-18.9m | $-23.0m
Free Cash Flow
$3.4m
Growth (TTM | estimate)
Revenue
11.3% | 6.6%
EBITDA
14.6% | 164.5%
EBIT
19.3% | -0.9%
Net Income
21.5% | -9.8%
Free Cash Flow
112.6%
Margin (TTM | estimate)
Gross
60.9%
EBITDA
-4.8% | 3.7%
EBIT
-5.4%
Net
-8.7% | -10.7%
Free Cash Flow
1.6%
More
EPS
$-0.1
FCF per Share
$0.0
Short interest
3.5%
Employees
622
Rev per Employee
$320.0k
Show more

Is Cerus Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Cerus Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Cerus Corporation forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a Cerus Corporation forecast:

Buy
80%
Hold
20%

Financial data from Cerus Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
216 216
11% 11%
100%
- Direct Costs 85 85
11% 11%
39%
132 132
12% 12%
61%
- Selling and Administrative Expenses 79 79
9% 9%
36%
- Research and Development Expense 65 65
7% 7%
30%
-10 -10
15% 15%
-5%
- Depreciation and Amortization 1.40 1.40
42% 42%
1%
EBIT (Operating Income) EBIT -12 -12
19% 19%
-5%
Net Profit -19 -19
22% 22%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Cerus Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cerus Corporation Stock News

Neutral
Business Wire
10 days ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly referred to as INTERCEPT Fibrinogen Complex, or IFC, at the 2025 Association for the Advancement of Blood and Biotherapies (AABB) Annual Meeting, taking place in San Diego, California from Octo...
Neutral
Business Wire
15 days ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET, during which management will discuss the Company's financial results and provide a general business overview and o...
Neutral
Business Wire
2 months ago
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the publication of a new recommendation from the German National Blood Advisory Committee (Arbeitskreis Blut or AK Blut), which recommends proactive measures, including pathogen inactivation (PI) such as INTERCEPT®, as core measures to enhance the safety of platelet transfusions. AK Blut is an expert committee th...
More Cerus Corporation News

Company Profile

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Head office United States
CEO Obi Greenman
Employees 622
Founded 1991
Website www.cerus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today